Purpose: The aim of this study was to explore the efficacy and dose effect of intradiscal injection of simvastatin sustained release hydrogel in the treatment of discogenic low back pain in rabbits.Methods: 36 female rabbits were randomly divided into G1 and G2 groups. In group G1, L1/2 was disc degeneration (group DDD), L2/3 was normal group (control group), L3/4 was medium dose treatment group (1mg/ml, DDD+ medium group), L4/5 was normal group, L5/6 was intervertebral disc degeneration + hydrogel segment (medium group). In group G2, L1 / 2 was degenerative segment, L2 / 3 was normal group, L3 / 4 was low-dose treatment segment (0.3mg/ml, DDD + low-dose group), L4 / 5 was normal group, L5 / 6 was high-dose treatment segment (3mg / ml, DDD + high-dose group). The intervertebral disc was evaluated by X-ray, MRI, water content, and hematoxylin-eosin.Result: At 12 and 24 weeks after treatment, the% DHI of control group and DDD + high were higher than those of DDD group and DDD + gel group (P <0.05); T2 image signal of the DDD+High group and Control group is better than DDD group, DDD+GEL group, DDD+ Medium and DDD +Low group (P <0.05). Intradiscal injection of simvastatin can delay disc degeneration and has a dose effect. At 4 and 12 weeks after treatment, the water content of intervertebral disc in control group and DDD + high group in control group were higher than DDD group, DDD + gel group and DDD + low group(P <0.05). Conclution:we verified the therapeutic efficacy and dose effect of simvastatin sustained-release system in rabbit DLBP model. The optimal treatment concentration was further optimized based on the dose gradient.